Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. the Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study.
Hebsgaard L, Nielsen TM, Tu S, Krusell LR, Maeng M, Veien KT, Raungaard B, Terkelsen CJ, Kaltoft A, Reiber JH, Lassen JF, Christiansen EH, Holm NR. Hebsgaard L, et al. Among authors: kaltoft a. Int J Cardiol. 2015 Mar 1;182:272-8. doi: 10.1016/j.ijcard.2014.12.088. Epub 2014 Dec 27. Int J Cardiol. 2015. PMID: 25585362 Free article.
Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial.
Kaltoft A, Nielsen SS, Terkelsen CJ, Bøttcher M, Lassen JF, Krusell LR, Kristensen SD, Ravkilde J, Kelbaek H, Bøtker HE, Christiansen EH, Rehling M, Thuesen L. Kaltoft A, et al. J Nucl Cardiol. 2009 Sep-Oct;16(5):784-91. doi: 10.1007/s12350-009-9105-x. Epub 2009 Jun 12. J Nucl Cardiol. 2009. PMID: 19521742 Clinical Trial.
Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial.
Kaltoft A, Kelbaek H, Kløvgaard L, Terkelsen CJ, Clemmensen P, Helqvist S, Lassen JF, Thuesen L. Kaltoft A, et al. J Am Coll Cardiol. 2010 Mar 2;55(9):867-71. doi: 10.1016/j.jacc.2009.09.052. J Am Coll Cardiol. 2010. PMID: 20185036 Free article. Clinical Trial.
Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Jensen LO, Maeng M, Thayssen P, Tilsted HH, Terkelsen CJ, Kaltoft A, Lassen JF, Hansen KN, Ravkilde J, Christiansen EH, Madsen M, Sørensen HT, Thuesen L. Jensen LO, et al. Among authors: kaltoft a. Am J Cardiol. 2012 Mar 1;109(5):629-35. doi: 10.1016/j.amjcard.2011.10.018. Epub 2011 Dec 5. Am J Cardiol. 2012. PMID: 22152969
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).
Jensen LO, Thayssen P, Junker A, Maeng M, Tilsted HH, Kaltoft A, Hansen KN, Christiansen EH, Kristensen SD, Ravkilde J, Madsen M, Sørensen HT, Thuesen L, Lassen JF. Jensen LO, et al. Among authors: kaltoft a. Am J Cardiol. 2012 Dec 1;110(11):1585-91. doi: 10.1016/j.amjcard.2012.07.022. Epub 2012 Sep 4. Am J Cardiol. 2012. PMID: 22959714 Clinical Trial.
Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study.
Holm NR, Sindberg B, Schou M, Maeng M, Kaltoft A, Bøttcher M, Krusell LR, Hjort J, Thuesen L, Terkelsen CJ, Christiansen EH, Bøtker HE, Kristensen SD, Lassen JF; CLOSE-UP study group. Holm NR, et al. Among authors: kaltoft a. EuroIntervention. 2014 Jun;10(2):183-90. doi: 10.4244/EIJV10I2A31. EuroIntervention. 2014. PMID: 24603054 Free article. Clinical Trial.
A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO. Maeng M, et al. Among authors: kaltoft a. Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1161-7. doi: 10.1002/ccd.25875. Epub 2015 May 6. Catheter Cardiovasc Interv. 2015. PMID: 25640050 Clinical Trial.
Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.
Jensen LO, Thayssen P, Christiansen EH, Maeng M, Ravkilde J, Hansen KN, Hansen HS, Krusell L, Kaltoft A, Tilsted HH, Berencsi K, Junker A, Lassen JF; SORT OUT IV Investigators. Jensen LO, et al. Among authors: kaltoft a. J Am Coll Cardiol. 2016 Feb 23;67(7):751-62. doi: 10.1016/j.jacc.2015.11.051. J Am Coll Cardiol. 2016. PMID: 26892409 Free article. Clinical Trial.
Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention.
Lønborg J, Kelbæk H, Holmvang L, Helqvist S, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi NP, Kløvgaard L, Kaltoft A, Bøtker HE, Lassen JF, Clemmensen P, Terkelsen CJ, Engstrøm T. Lønborg J, et al. Among authors: kaltoft a. Am J Cardiol. 2016 Jun 1;117(11):1735-40. doi: 10.1016/j.amjcard.2016.03.009. Epub 2016 Mar 18. Am J Cardiol. 2016. PMID: 27062938 Clinical Trial.
112 results